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Abstract
Objective. To examine the demographic, physical,
and mental health characteristics; current drug use
patterns; motivations for use; and diversion sources
among elderly prescription opioid misusers.
Design. Mixed methods design.
Setting. Research field offices, or senior or commu-
nity center offices in South Florida.
Subjects. Individuals aged 60 and over reporting
past 90-day prescription medication misuse; only
prescription opioid misusers (N = 88) were included
in the final analysis.
Methods. The Global Appraisal of Individual Needs
was the main survey instrument. A subsample
of elderly reporting substantial prescription drug
misuse were chosen for the in-depth interview
(N = 30).
Results. The mean age was 63.3. Fifty percent
reported ever being admitted to a drug treatment
program; several endorsed recent illicit drug use:
powder cocaine and/or crack (35.2%), marijuana
(30.7%), heroin (14.8%). The majority reported past
year severe physical pain and discomfort (86.4%),
and misuse of their primary opioid for pain (80.7%);
over half (52.3%) obtained their primary opioid from
their regular doctor. Qualitative data highlight the
misuse of prescription opioids due to untreated or
undertreated pain. Participants with primary opioid
misuse for pain had over 12 times higher odds of
obtaining the medication from their regular doctor
(odds ratio [OR] = 12.22, P = 0.002) and had lower
odds of using a dealer (OR = 0.20, P = 0.005).
Conclusions. Findings suggest that this group of
elderly participants often misuse their own prescrip-
tions for pain management. This study highlights
the need to educate prescribing professionals on
appropriate pain management for older adults while
still being sensitive to issues of substance abuse
and dependence.
Key Words. Older Adults; Pain Management; Sub-
stance Abuse; Opioids
Introduction
Chronic, noncancer pain is often associated with increas-
ing age [1,2]. Findings from the National Health and Nutri-
tion Examination Survey indicated that 57% of individuals
65 and over reported noncancer pain that lasted 1 year or
more [3]. Another community-based survey documented
that 35.7% of individuals aged 60–69 experienced pain
throughout the day [2]. Although it has been estimated
that 45–85% of elderly persons in various settings expe-
rience chronic, noncancer pain, less than half are effec-
tively treated by their general practitioners [4]. Research
on individuals 18 and over found that more than one third
of patients continued to be unsatisfied with the treatment
offered for their chronic pain condition [1], and for the
elderly specifically, it has been reported that over 40%
experienced daily pain with only one quarter receiving any
analgesic [5]. The undertreatment of noncancer pain in
older adults has been attributed to both provider and
patient factors [6]. At the provider level, there is inad-
equate screening and identification [7], and a lack of train-
ing in treating pain [6]; contributors to the undertreatment
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of pain at the patient level include underreporting, cogni-
tive decline, and attitudes regarding pain as part of the
aging process [6,8].
Reports of national survey data indicate that in recent
years, prescription opioid misuse has been on the rise [9].
Prescription opioid misuse has also been associated
with increased prescription drug diversion (the unlawful
channeling of regulated pharmaceuticals from legal
sources to the illicit marketplace) through the illegal sale
and recycling of prescriptions by physicians and pharma-
cists; “doctor shopping” by individuals who visit numerous
physicians to obtain multiple prescriptions; theft, forgery,
or alteration of prescriptions by patients; robberies and
thefts from manufacturers, distributors, and pharmacies;
street buys; and sharing with friends [10,11]. Research
has indicated that the therapeutic exposure to opioids can
correspond to increases in misuse [12]. The fear of abuse
or the development of addiction among patients, coupled
with scrutiny from regulatory agencies such as the Drug
Enforcement Administration (DEA) are barriers that often
result in the failure to adequately treat pain symptoms
[13–15]. Although chronic pain has been documented by
some as a factor associated with prescription drug misuse
[16] or a common reason for the nonmedical use of pre-
scription pain medications [17,18], few studies focus on
the misuse of prescription pain medications among older
adults outside of drug treatment settings. Moreover, little is
known about the specific motivations for prescription
opioid misuse and diversion among the elderly.
Although substance abuse is rarely associated with indi-
viduals nearing or at a retirement age [19,20], there is an
increasing need to understand the nature and extent of
drug use among older adult populations. With the baby
boomer population (those born between 1946 and 1964)
beginning to reach their 50s and 60s, 10,000 people will
turn 65 everyday and continue to do so for the next 20
years; by 2030, one out of every five Americans will be 65
or older [21]. This population increase, coupled with
greater lifetime drug use than previous generations [22],
will likely produce unprecedented high numbers of older
adult drug users [23–30].
When looking at recent survey data for older adults, the
Substance Abuse and Mental Health Services Administra-
tion [24] reported that 4.7% of adults over 50 had used an
illicit drug in the past year, with marijuana being the most
commonly used (2.8%) followed by the nonmedical use of
prescription medications (2.1%). Among adults over 65,
nonmedical use of prescription-type drugs was most
common (0.8%).
Given these increases, there will undoubtedly be an
increased call for drug treatment programs tailored to the
ever-changing needs of elderly patients [23,30]. Some
estimates have documented up to a 70% increase in the
rate of treatment need among older adults [25]. When
examining existing findings, Lowfall et al. [30] reported a
significant growth in substance abuse treatment admis-
sions for older adults between 1992 and 2005; in 2005,
10% of all admissions were age 50 and over. Results
showed a growing proportion of older aged admissions for
polysubstance and illicit drug abuse, particularly cocaine
and heroin abuse. Moreover, data taken from the Treat-
ment Episode Data Set (TEDS) [31,32] indicated some
notable increases among the primary substances of
abuse for adults 60 and over: sedative as primary drug
jumped from 1.7% in 2002 to 5.2% in 2007; heroin went
from 0.9% in 2002 to 1.5% in 2007; smoked cocaine
doubled from 0.5% in 2002 to 1% in 2007; and opiate
abuse remained stable across this time period. These data
indicate an increasing trend of illicit drug and sedative
abuse among this aging population.
Most recent research on older adult populations has
originated from cross-sectional national survey data
[17,19,23,25,28,32,33]. While several publications have
projected substance use disorder among older adults (50
and older) and baby boomers [23,25,26,33], or discussed
substance abuse-related treatment needs specific to this
population [26,27,34–36], few studies have specifically
examined the characteristics, sources, and motivations for
prescription drug misuse among those over the age of 60
[17,24,37,38]. Furthermore, little is known about the
misuse of prescription opioids for untreated pain among
older adult populations.
In order to focus on this distinct and understudied popu-
lation, we examined data from individuals aged 60 and
over who had recently misused prescription medications.
The unique nature of the present study is that it specifically
targeted elderly outside of treatment settings. This article
examines demographic, physical, and mental health char-
acteristics, and current drug use patterns and sources
among elderly prescription opioid misusers in South
Florida. We also report results from qualitative interviews
that explored motivations and other factors associated
with prescription opioid misuse.
Methods
Participants
The South Florida Health Survey, a 4-year mixed
methods study funded by the National Institute on Drug
Abuse, examined prescription drug misuse and diversion
among six subpopulations in South Florida. Eligible par-
ticipants were 18 years of age or older, and reported
misuse of psychoactive prescription drugs (opioids,
stimulants, sedatives, antidepressants, or antipsychotics)
at least five times in the past 90 days. For the purposes
of the study, prescription drug misuse was defined as
either using medication without a doctor’s prescription
or using more of a medication than prescribed. In
screening for the study, we did not assess specifically for
substance dependence, typically characterized by crav-
ings, compulsion to use, inability to control use, and
continued use despite negative consequences [39]. Par-
ticipants were also required to meet one of the following
criteria that determined the subpopulation they repre-
sented: 1) methadone clients (N = 301); 2) street drug
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users (N = 301) who reported current illicit drug use; 3)
public treatment clients (N = 300) and 4) private-
treatment clients (N = 301), both of which were enrolled
in drug treatment for fewer than 45 days prior to the
interview; 5) men who have sex with men (MSM;
N = 301) who reported current illicit stimulant use; and 6)
elderly aged 60 and above (N = 126). This report only
includes elderly participants who reported prescription
opioid misuse in the past 90 days (N = 88).
Measures
Prior research has documented that those most likely to
progress from opioid misuse to abuse are often in
pain, with many possessing comorbid medical and psy-
chiatric conditions [40]. Moreover, for substance abusers
in treatment, increased age was found to be associated
with debilitating pain, deteriorating mental health, and
the use of medical channels as the primary source for
opioids [37]. These findings informed the selection of
the demographic, and physical and mental health factors
utilized for this analysis. The Global Appraisal of Indi-
vidual Needs (GAIN) [41] was the primary data collection
instrument for the survey study. Psychometric studies
have found Cronbach’s alphas between 0.9 and 0.8;
specifically, for the General Mental Distress Scale
(GMDS), the Substance Dependence Scale, and the
Health Distress Scale (HDS), Cronbach’s alphas are
at 0.8, and behavior questions have demonstrated test-
retest correlations over 0.8 [42]. The GAIN has eight
core sections including: demographics; mental and
physical health; human immunodeficiency virus (HIV)
risk behaviors; environmental, legal, and vocational mea-
sures; and substance use, abuse, and dependence
measures based on Diagnostic and Statistical Manual of
Mental Disorders IV (DSM-IV) criteria. Questions were
added to the GAIN to increase the specificity of pres-
cription drugs queried, including both opioids (fentanyl,
hydrocodone, hydromorphone, immediate release [IR]
and extended release [ER] oxycodone, morphine,
methadone, and codeine) as well as benzodiazepines
(alprazolam, diazepam, and clonazepam). The assess-
ment instrument captured a complete illicit and non-
medical prescription drug history, including number of
days use in the past 90 days.
The primary opioid misused in the past 90 days was
determined from the database using the number of days;
in cases of ties, the number of pills ingested in the past 90
days was used to determine primary opioid. The primary
opioid diversion source used by each respondent in the
past 90 days was determined from the database; partici-
pants may have endorsed using more than one source. In
order to assess the motivations for past 90-day primary
opioid misuse, participants were asked: “What is your
main reason for using this drug?” (pain, anxiety or stress,
get high, to substitute for another drug, to moderate other
drug effects, to sleep, social pressure, and others);
respondents may have reported more than one motivation
for each endorsed drug.
Participants were also asked what method they used to
obtain each diverted prescription drug they misused in the
past 90 days. Diversion methods included script doctors,
doctor shopping, regular doctor, pharmacist, theft, dealer,
sharing and trading, family members, transport from
another country, or Internet purchase; response choices
were dichotomous (yes/no).
Mental distress was measured by the GMDS, which
includes depression (e.g., feeling sad, lonely, or hope-
less; feeling tired or having no energy) and anxiety (e.g.,
feeling nervous, anxious, or tense; unable to control
worries) experienced in the past 12 months; response
choices were dichotomous (yes/no). For the purpose
of this analysis, endorsement of six or more out of
nine depressive symptoms was categorized as severe
depression, and seven or more anxiety symptoms out of
12 was categorized as severe anxiety. In order to assess
DSM-IV dependence, respondents were asked seven
questions to assess dependence symptoms for each
drug used (response choices were: never, more than a
year ago, 7–12 months ago, 4–6 months ago, 1–3
months ago, 1–4 weeks ago, or I don’t know); endorse-
ment of three or more of these symptoms in the past
year from the following seven categories constituted
DSM-IV dependence: tolerance, withdrawal, use in larger
amounts, inability to cut down, great effort to obtain the
drug, reduction or problems related to important activi-
ties resulting from use, and continued use despite physi-
cal and psychological problems.
Respondent demographic characteristics including age,
gender, and race/ethnicity (African American/Caribbean,
Hispanic/Latino, White, Other) were reported. Respon-
dents were asked, “In the past 12 months would you
say your health was: excellent, very good, good, fair, or
poor?” and “when was the last time you experienced
health or medical problems?” (never, more than 12
months ago, 4–12 months ago, in the past 90 days).
Those endorsing past 90-day health or medical prob-
lems were asked, “What is the problem you have
been having?” The response to this question was
recorded verbatim. To measure pain, an item from
GAIN’s HDS was selected: “During the past 12 months,
have you had a lot of physical pain or discomfort?”
In addition, participants were asked whether they
had any health insurance in the past 90 days, whether
they had been homeless in the past year, whether they
had ever been admitted to drug treatment, and whether
they had sold any prescription medication in the last
90 days; these response choices were dichotomous
(yes/no).
A subsample of elderly who reported substantial pre-
scription drug misuse and multiple diversion methods
were chosen from the quantitative study for the in-
depth interview (N = 30). The in-depth interviews were
designed to gather qualitative data regarding prescrip-
tion drug abuse initiation, motivations for prescription
drug misuse, drug abuse patterns, and prescription
drug diversion sources. The interview guide included
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questions such as: How did you start abusing pre-
scription drugs?; What were the main reasons?; What
are the current reasons for abusing prescription drugs?;
What are the different ways you obtain these drugs?;
and How does prescription drug abuse affect your
health? The goal of the qualitative component of the
study was to gather more detailed information about
drug use history, diversion sources, and motivations
for use. All in-depth interviews were transcribed verbatim
for analysis.
Procedures
Study recruitment procedures have been described
previously [43,44]. Elderly recruitment was conducted
through a variety of purposive sampling strategies includ-
ing print media advertisements, the posting or manual
distribution of cards and flyers, chain referrals with incen-
tives, and presentations at senior centers, the Broward
County Department of Veteran Affairs outpatient clinic,
and community health centers. As a result of specific
recruitment challenges, such as reluctance to participate
in telephone screening or to discuss personal information,
126 elderly participants were ultimately recruited.
The study was conducted in the investigators’ research
field offices or in senior or community center offices in
Broward, Lee, Miami-Dade and Palm Beach Counties. All
participants were screened for eligibility by trained
research staff prior to participation in a single, standard-
ized face-to-face interview. Following informed consent,
computer-assisted or in-depth interviews were conducted
in private offices and lasted between 1 and 2 hours.
Participants received a $30 monetary stipend for their
time. All study protocols and instruments were approved
by the University of Delaware (predecessor institution) and
Nova Southeastern University Institutional Review Boards.
Analyses
Data were analyzed using IBM SPSS Statistics, version 20
(International Business Machines Corp., Raleigh, NC,
USA). Descriptive statistics were calculated to describe
the sample in terms of demographics, physical and mental
health status, substance use, DSM-IV past year depen-
dence, recent (past 90 day) primary opioid of abuse and
recent (past 90 day) primary opioid diversion source.
Primary opioids included codeine, hydrocodone, hydro-
morphone, morphine, fentanyl, methadone, IR and ER
oxycodone, and tramadol; the benzodiazepine group
included alprazolam, clonazepam, and diazepam. Bivari-
ate logistic regression models were constructed to predict
diversion source for primary opioid by demographics,
physical and mental health characteristics, and recent illicit
drug and opioid use. Significance level was set at P < 0.05
for all comparisons.
The primary author conducted multiple readings and
coding of all in-depth interview transcripts to identify salient
themes. Although guided by the quantitative findings, there
were no predetermined categories used to code the data.
A grounded theory approach was selected for the data
analysis because it allows for the participant explanations
to inform or explain the phenomenon or social process [45].
For the purpose of this manuscript, a content analysis of
the 30 interviews was conducted to ascertain motivations
for prescription opioid misuse. Initial coding was per-
formed through a thorough word-by-word reading of the
transcripts to identify the current reasons for using pre-
scription opioids. After this initial coding was conducted,
more focused coding was used to identify the most fre-
quently occurring themes, including the misuse of medi-
cations to manage pain. Finally, the major concepts and
categories were conceptualized, and each one was
assigned the quotes that best illustrated them.
Results
Demographics
Sample characteristics are displayed in Table 1. The mean
age of the sample was 63.3 (standard deviation [SD] 4.6;
range 60–84; 86.4% of the sample was age 60–65); the
sample was predominately male (75%). The racial/ethnic
makeup of the sample represents the broad diversity of
South Florida’s population: 36.4% were African American/
Caribbean; 37.5% were White; 20.5% were Hispanic/
Latino; and 5.6% endorsed “other race/ethnicity.” Less
than half had more than a high school education (42%).
The majority of participants had health insurance (73.9%).
Less than half (46.6%) of the respondents had an income
over $1,000 per month; 61.4% had disability or social
security as their income source. More than one quarter
(28.4%) reported being homeless in the past 90 days.
Over two thirds (77.3%) had ever been arrested, and 50%
had ever been admitted to drug treatment. Nearly one
quarter (23.7%) of the sample reported being a veteran. A
small percentage of the sample (10.2%) reported having
sold prescription medication in the past 90 days.
When examining physical and mental health, 70.4%
reported fair or poor health in the past year, and the vast
majority endorsed past year severe physical pain and
discomfort (86.4%). Out of the 88 participants, 67 (75%)
reported past 90-day health or medical problems; of
these, 36.4% (N = 24) reported back- or disc-related pain,
followed by arthritis pain by 25.8% (N = 17), and various
other pain conditions. Past year severe depression was
reported by 44.3% of the sample, while severe anxiety
was reported by 28.4%. In terms of motivations for
primary opioid misuse, 80.7% (N = 71) endorsed misusing
their primary opioid for pain, distantly followed by 14.8%
(N = 13) reporting misuse to get high, and 14.8% (N = 13)
“to substitute for another drug.”
Recent (Past 90-Day Drug Abuse)
Table 1 shows the drugs of abuse/misuse in the past 90
days for the sample: alcohol (63.6%), benzodiazepines
(48.9%), powder cocaine and/or crack (35.2%), marijuana
(30.7%), heroin (14.8%), prescription antidepressants
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Table 1 Characteristics of elderly prescription opioid abusers in South Florida (N = 88)
Demographics N %
Age (mean, SD) 63.3 (4.6)
Male gender 66 75
Ethnicity
African American/Caribbean 32 36.4
White 33 37.5
Hispanic 18 20.5
Other 5 5.6
Ever arrested 68 77.3
Income over $1,000 per month 41 46.6
Income source: disability or social security 54 61.4
Homeless in past 90 days 25 28.4
Ever admitted to drug treatment 44 50.0
Education: more than HS 37 42.0
Veteran 21 23.7
Sold medication in the past 90 days 9 10.2
Physical health
Health insurance 65 73.9
Medicare/medicaid 49 55.7
Private insurance 4 4.5
Past year health—fair or poor 62 70.4
Recent (past 90 days) physical problems 66 75.0
Past year severe physical pain or discomfort 76 86.4
Recent (past 90 days) primary opioid misuse for pain 71 80.7
Mental health
DSM-IV past year dependence 13 14.8
Severe depression in the past 12 months 39 44.3
Severe anxiety in the past 12 months 25 28.4
Past 90-day drug use
Alcohol 56 63.6
Marijuana 27 30.7
Heroin 13 14.8
Cocaine or crack 31 35.2
Opioids 88 100.0
Benzodiazepines 43 48.9
Prescription antidepressants 9 10.2
Prescription antipsychotics 12 13.6
Past 90-day primary opioid
IR or ER oxycodone 34 38.6
Tramadol 18 20.5
Hydrocodone 14 15.9
Recent primary opioid diversion source
Regular doctor 46 52.3
Dealer 26 29.5
Sharing 26 29.5
Family 7 8.0
Script doctor 2 2.3
Pharmacy 1 1.1
ER = extended release; HS = high school; DSM-IV = Diagnostic and Statistical Manual of Mental Disorders IV; IR = immediate
release; SD = standard deviation.
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(10.2%), and prescription antipsychotics (13.6%). The
primary opioids of abuse were oxycodone (38.6%), fol-
lowed by tramadol (20.5%) and hydrocodone (15.9%).
DSM-IV criteria for substance dependence in the past
year were met by 14.8% of respondents.
Recent Primary Opioid Diversion Source
Sources of diversion for prescription medications varied
among respondents. Regular doctor was the most
popular source among respondents (52.3%), followed by
dealer (29.5%), sharing and trading (29.5%), family (8%),
script doctor (2.3%), and pharmacy (1.1%).
Table 2 shows the odds ratios (ORs) for diversion source.
Whites, Hispanics, and those endorsing “other” ethnicity
had significantly lower odds of obtaining their primary
opioid from their regular doctor as compared with the
African American/Caribbean reference group. Individuals
who had ever been arrested had nearly five times higher
odds of obtaining their primary opioid from a dealer
(OR = 4.91, P = 0.043); individuals with disability or social
security as an income source had significantly lower odds
of using a dealer (OR = 0.26, P = 0.005), whereas those
who endorsed being homeless in the past 90 days had
over three times higher odds of having a dealer as their
source (OR = 3.23, P = 0.020). Veterans had nearly four
times higher odds of acquiring their primary opioid via a
regular doctor (OR = 3.95, P = 0.016) and were also sig-
nificantly less likely to obtain medication through sharing
or trading with others (OR = 0.19, P = 0.034).
Certain physical health characteristics were also signifi-
cantly associated with primary opioid diversion source.
Respondents with health insurance had over three times
higher odds of using a regular doctor (OR = 3.43,
P = 0.018) and had lower odds of using either a dealer
(OR = 0.33, P = 0.029) or sharing (OR = 0.25, P = 0.007).
Participants endorsing recent physical problems had
lower odds of using a dealer (OR = 0.22, P = 0.004), while
those who endorsed recent primary opioid misuse for pain
had over 12 times higher odds of using a regular doctor to
obtain their primary opioid (OR = 12.22, P = 0.002) and
had significantly lower odds of using a dealer (OR =
0.20, P = 0.005). None of the mental health variables
were significant.
Recent illicit drug use had several associations to primary
opioid diversion source. Alcohol users had over four times
higher odds of using a dealer (OR = 4.53, P = 0.012) and
over three times higher odds of obtaining medication via
sharing (OR = 3.24, P = 0.036). Marijuana users had over
four times higher odds of using a dealer (OR = 4.40,
P = 0.003) and lower odds of using a regular doctor
(OR = 0.32, P = 0.020). Although heroin, cocaine or
crack, and benzodiazepine users were all less likely to use
a regular doctor to acquire their primary opioid, benzodi-
azepine users had over four times higher odds of using a
dealer (OR = 4.30, P = 0.005). When examining primary
opioid misuse by source, IR or ER oxycodone misusers
had higher odds of using a dealer (OR = 2.85, P = 0.030)
but lower odds of obtaining primary opioid through their
regular doctor (OR = 0.31, P = 0.012). Tramadol misusers
had over 10 times higher odds of obtaining their opioid
through a regular doctor (OR = 10.76, P = 0.003) but had
lower odds of acquiring them through a dealer (OR = 0.11,
P = 0.034).
Qualitative Data
Out of the 30 qualitative respondents, 10 were veterans,
20 had illicit drug use histories, and 15 were misusing their
own prescriptions. The primary theme that emerged in the
qualitative analysis was opioid misuse to achieve pain
relief; in this regard, 10 individuals specifically discussed
the need to take more medication because the amount
prescribed was not enough to manage their pain. Other
less common themes included: misusing opioid medica-
tion to avoid drug withdrawal, misuse of opioid medication
to sleep, and misuse of opioid medications to manage
symptoms of anxiety or depression.
This analysis highlights the findings on the misuse of pre-
scription opioids due to untreated or undertreated pain.
Three main themes emerged: 1) the misuse of legitimately
prescribed medications to manage pain; 2) reluctance of
physicians to prescribe high dose/potency pain medica-
tions; and 3) participant need to purchase pain medication
from other sources due to lack of legitimate prescriptions
or insurance.
Misuse of Legitimate Prescriptions
Several participants misused their own legitimately pre-
scribed medications for pain management. As one
61-year-old male described:
Sometimes man I’ll take more than they prescribe a
day, just in order to get through the pain man . . .
One extra a day.
A 64-year-old male described:
The prescription on the Percocet is one every 4
hours. If the pain doesn’t go away I might drop
another one before the four hours is over with. It all
depends on the pain level . . . It’s only when the
pain is intense that I may (go over the prescribed
amount) . . . Maybe 4 times in a month I do that.
Similarly, a 65-year-old male veteran explained:
Tramadol. I am supposed to take three a day,
sometimes the pain is so bad that I take 5 . . .
As a result of misusing their own medications, some par-
ticipants described having to buy medication on the street
or from other sources because they ran out of their own
prescription before it was time to have it refilled.
According to a 61-year-old disabled male veteran:
They give me a prescription with 90 pills in it. That
is for 3 months . . . Half of the month, the first
month, I be down there tellin them I need some
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more pills. And they be like, nah we cant give you
no more. So I go out and buy em’. Oxycodone for
my knees and stuff like that . . . These pills (his
prescription) I take at least 5 of these at one time.
I take 5 of each, so I take 15 pills at one time
(tramadol, acetaminophen, and cyclobenzaprine).
Sometimes if I have some oxycodone I’ll take 2 of
them. On top of that . . . Sometimes the pills wear
off and the pain come back and I take some more
. . . The prescription that they gave me, the
amount that they tell me to take, just don’t do
nothin. So I take more than what they tell me
to take.
One 64-year-old male explained:
Sometimes go out, if I am in a lot of pain, you know,
like I get from like a friend. You know, I’m out of my
pain medicine and my back and stuff be buggin me
. . . So that’s why they was givin me the medica-
tion, my back. it all depends on how I was feelin. If
the pain is real real bad I double up. I might mix. If
my doctor give me another prescription I mix them
all up to get rid of the pain. I be in pain . . .
A 61-year-old male veteran:
Sometimes I take some pills, my niece, she have uh
spinal problem, a lower spinal problem. And she
has uh I don’t know if you ever heard of it, oxyc-
odone, yeah now that works . . . little blue pill. I get
like 12 from her and I give her like $10.00 . . .
Physician Reluctance to Prescribe High
Dose/Potency Opioids
Some participants stated that their physician was reluc-
tant to prescribe large doses of pain medication. A
61-year-old woman described:
Because I didn’t want to get hooked like most
people, you know, cause I wasn’t taking em’ for
that reason. To get high and that. I was taking them
because I was in pain, and my doctor had told me
the reason he didn’t want to give them to me was
because he didn’t want me to get hooked. And I
always keep things like that in my mind. So that’s
why I cut back.
A 61-year-old male veteran explained:
For my pain. Not to abuse them, not cause they get
me high. Sometimes the medicine wears off before
it’s supposed to. It is supposed to last a certain
amount of time but it don’t. Other medicine I guess,
I don’t know what the reason is. I even told the
doctor. He said you have to suffer through the pain.
Yeah, right.
Some respondents also described the prescribing of low-
dose medications. One 64-year-old male explained:
One time they be prescribing ibuprofen and you
know, that one ain’t doin no, ain’t killin no pain. I
might have to take a whole bottle and still be in
pain.
Lack of Legitimate Prescriptions or Insurance
Some respondents endorsed getting needed pain medi-
cations from other sources due to lack of legitimate pre-
scriptions. According to a 60-year-old male:
I had 8 Percocet I got from a guy I know, you
know, for pain. And believe me those percs stop
the pain. They are powerful . . . For anybody that
got pain that cures it. It’s really some good stuff
for pain.
One 60-year-old homeless male described buying pills on
the street because he has no insurance:
. . . As the days go by the knee gets worse and
worse now and using relatively, well a strong pain
killer just because now I have to walk everywhere,
there is an abnormal amount of stress on the knee
because sometimes you are sleeping on a side-
walk, not necessarily sleeping on a bed . . . .Pain.
For pain. When you’re out on the streets and you
are trying to get a job you just, you can’t be weak.
So to speak. You can’t have any maladies that slow
you down. You gotta be on top of your game.
Especially, and I’m 60 so it’s quite harder to get a
job than it is somebody 28, 29. I gotta be in that
field. If somebody says you know, you gotta be at
an interview I gotta be either prepared to walk to it
or whatever because I don’t have a car . . . See I
don’t need this stuff . . . I am just at a particular
point where right now it has to be done. I have to
take it until I have to get my knee repaired.
Discussion
These results reflect a marginalized group of elderly indi-
viduals, many with substance abuse histories, that are
being undertreated for their pain. For our sample, the
majority had health insurance, allowing ease of access to
doctors for visits and for medications via pharmacy ben-
efits; this perhaps made obtaining prescriptions more eco-
nomically feasible for this indigent population. Our findings
relating to regular doctor as the primary source of pre-
scription opioids is consistent with prior national studies of
individuals in treatment for opioid abuse [38]. For aging
treatment populations specifically, Cicero et al. found that
respondents over the age of 45 had much higher odds of
using a doctor as their source for prescription opioids,
suggesting that perhaps it is easier for aging patients with
pain to get a doctor’s prescription [37].
Although patients have access to medications through
physicians, it appears that they are often prescribed
lower potency medications, making under treatment of
pain a significant issue. The qualitative analysis comple-
ments the quantitative data in its illustration of the
misuse of prescribed medications for untreated or under-
treated pain. Prior research findings have indicated that
the elderly may be in a position to deceive physicians by
complaining of pain in order to get the prescriptions they
desire [46]; our findings suggest that prescription opioid
medications may be under prescribed to legitimate
patients (in terms of number and potency), causing indi-
viduals to take more than indicated to achieve adequate
pain relief. Qualitative findings support the idea that
doctors seem to be cautious about the types of medi-
cations prescribed. Very few participants were pre-
scribed higher potency opioids such as oxycodone,
which could likely be due to recent local crackdowns on
physicians prescribing pain medications [47] or a
concern that patients may develop dependence on pre-
scription opioids [16]. Respondents had over 10 times
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higher odds of obtaining tramadol from their regular
doctor but were less likely to use a dealer, which further
supports the idea that doctors are wary of prescribing
scheduled medications possibly due to legal concerns
related to abuse, misuse, diversion, or fear of investiga-
tion by law enforcement [14].
Our findings also support previous findings that with
increasing age, individuals with substance abuse histories
are likely to have increased pain and other serious medical
issues associated with long-term substance abuse [37].
Many respondents in the sample reported extensive drug
use histories and recently used illicit drugs such as mari-
juana, heroin, or cocaine or crack, increasing the likeli-
hood that individuals from this sample are being treated
for medical complications associated with substance
abuse. Although substance abuse is clearly on the rise
among older adult populations [19], our sample encom-
passes individuals who likely possess more severe sub-
stance abuse involvement and associated life problems
than the average older adult. Despite this, there remains
an important need to research the continued use of illicit
drugs and their effects on the aging brain [23]; moreover,
it will be essential to integrate drug treatment modalities
that encompass medical as well as behavioral health ser-
vices [24]. In terms of mental health, our findings that over
40% of our sample reported past year severe depression
and nearly 30% experienced severe anxiety are also con-
sistent with prior research documenting that depression or
other types of psychological distress are often associated
with chronic pain [48].
There are several limitations to this study. First, we have a
rather small sample size (N = 88), with the majority being
under the age of 70. This group of elderly individuals living
within the community has unique characteristics including
illicit drug use histories. This makes it difficult to generalize
our results to other senior populations. The study also
relies on the use of self-report data that are subject to
reporting and social desirability bias and recall problems.
This research is also based on cross-sectional data, which
does not allow for the examination of changes over time.
Because the original study was not designed to assess
clinical aspects of chronic pain conditions, specific infor-
mation regarding the origins and other types of treatments
to manage pain were not collected. Those in the sample
who were prescribed and were regularly taking opioids for
pain may have also developed some level of tolerance and
physical dependence, creating a difficulty in truly assess-
ing DSM-IV dependence.
Conclusions
Despite these limitations, our findings suggest that this
group of elderly participants often misuse their own pre-
scriptions for pain. With prescription opioid misuse on the
rise, there is an ongoing need to understand the factors
involved in opioid misuse, particularly among older popu-
lations in order to combat addiction and prescription drug
diversion. Moreover, these findings have implications
when considering the treatment of pain in elderly. Our data
highlight the need for continued education and training for
physicians and others prescribing pain medications to
older populations. In order to ensure the proper prescrib-
ing of prescription drugs while being sensitive to diversion
and misuse, there is a continued need to educate pre-
scribing professionals on substance abuse identification
(including screening for risk factors and identifying the
warning signs of drug addiction), as well as to implement
screening questionnaires at routine checkups [49]. Among
patients with an increased risk for misuse, including those
who are younger in age, have current, past, or family
history of substance abuse or concurrent psychiatric dis-
orders, it has been suggested that prescribing physicians
utilize treatment contracts, structured prescribing, and
urine testing [39]. This will facilitate the process of pre-
scribing appropriately, while at the same time aiding in the
identification of substance abuse or dependence so treat-
ment referrals can be made for older adults in need.
It has also been recommended that physicians take steps
to combat misuse through: working with their patients
prior to prescribing these medications in order to clearly
define the therapeutic goals; and to discuss the risks and
benefits associated with long-term opioid therapy. Fur-
thermore, the ongoing reassessment of these goals at
follow-up appointments through discussions of adverse
effects and safe and responsible use have also been
indicated [6,8]. Screening tools and medication agree-
ments are also valuable tools to use with those being
prescribed opioids as part of ongoing pain management
[36].
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